Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)

Federal funding opportunity PAR-25-056 from National Institutes of Health (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• Public and State controlled institutions of higher education
• County governments
• For profit organizations other than small businesses
• State governments
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Small businesses
• Native American tribal organizations (other than Federally recognized tribal governments)
• Special district governments
• Independent school districts
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• City or township governments
• Private institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities/Indian housing authorities

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

The official record

Similar grants

• NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
  PAR-25-447 · National Institutes of Health · closes May 8, 2028
• NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
  PAR-25-025 · National Institutes of Health · closes January 7, 2027
• NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
  PAR-25-026 · National Institutes of Health · closes January 7, 2027
• Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
  PAR-24-330 · National Institutes of Health · closes September 7, 2027
• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
  PA-26-001 · National Institutes of Health · closes November 30, 2028
• Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
  PAR-24-296 · National Institutes of Health · closes December 3, 2026